# Autozone Inc: financial statements, quarterly

AZO · NYSE · CIK 866787 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Aug 29

Pages: [Overview](/companies/azo.md) · [Financials](/companies/azo/financials.md) · [Filings](/companies/azo/filings.md) · [Insiders](/companies/azo/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/azo/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2023 (2022-11-19) | Q2 FY2023 (2023-02-11) | Q3 FY2023 (2023-05-06) | Q1 FY2024 (2023-11-18) | Q2 FY2024 (2024-02-10) | Q3 FY2024 (2024-05-04) | Q1 FY2025 (2024-11-23) | Q2 FY2025 (2025-02-15) | Q3 FY2025 (2025-05-10) | Q1 FY2026 (2025-11-22) | Q2 FY2026 (2026-02-14) | Q3 FY2026 (2026-05-09) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,985](/filings/0001558370-23-019871.md) | [3,691](/filings/0001558370-24-003413.md) | [4,091](/filings/0001558370-24-009005.md) | [4,190](/filings/0001558370-24-016435.md) | [3,859](/filings/0001558370-25-003476.md) | [4,235](/filings/0001558370-25-008618.md) | [4,280](/filings/0001104659-25-123222.md) | [3,952](/filings/0001104659-26-032757.md) | [4,464](/filings/0001104659-26-073525.md) | [4,629](/filings/0001104659-25-123222.md) | [4,274](/filings/0001104659-26-032757.md) | [4,841](/filings/0001104659-26-073525.md) |
| Cost of revenue | $m | [1,990](/filings/0001558370-23-019871.md) | [1,761](/filings/0001558370-24-003413.md) | [1,944](/filings/0001558370-24-009005.md) | [1,976](/filings/0001558370-24-016435.md) | [1,779](/filings/0001558370-25-003476.md) | [1,970](/filings/0001558370-25-008618.md) | [2,012](/filings/0001104659-25-123222.md) | [1,824](/filings/0001104659-26-032757.md) | [2,111](/filings/0001104659-26-073525.md) | [2,269](/filings/0001104659-25-123222.md) | [2,031](/filings/0001104659-26-032757.md) | [2,316](/filings/0001104659-26-073525.md) |
| Gross profit | $m | [1,995](/filings/0001558370-23-019871.md) | [1,930](/filings/0001558370-24-003413.md) | [2,146](/filings/0001558370-24-009005.md) | [2,214](/filings/0001558370-24-016435.md) | [2,080](/filings/0001558370-25-003476.md) | [2,266](/filings/0001558370-25-008618.md) | [2,268](/filings/0001104659-25-123222.md) | [2,128](/filings/0001104659-26-032757.md) | [2,354](/filings/0001104659-26-073525.md) | [2,359](/filings/0001104659-25-123222.md) | [2,243](/filings/0001104659-26-032757.md) | [2,525](/filings/0001104659-26-073525.md) |
| Selling, general and administrative | $m | [1,272](/filings/0001558370-23-019871.md) | [1,260](/filings/0001558370-24-003413.md) | [1,288](/filings/0001558370-24-009005.md) | [1,365](/filings/0001558370-24-016435.md) | [1,336](/filings/0001558370-25-003476.md) | [1,365](/filings/0001558370-25-008618.md) | [1,427](/filings/0001104659-25-123222.md) | [1,422](/filings/0001104659-26-032757.md) | [1,487](/filings/0001104659-26-073525.md) | [1,575](/filings/0001104659-25-123222.md) | [1,545](/filings/0001104659-26-032757.md) | [1,601](/filings/0001104659-26-073525.md) |
| Operating income | $m | [723](/filings/0001558370-23-019871.md) | [670](/filings/0001558370-24-003413.md) | [858](/filings/0001558370-24-009005.md) | [849](/filings/0001558370-24-016435.md) | [743](/filings/0001558370-25-003476.md) | [900](/filings/0001558370-25-008618.md) | [841](/filings/0001104659-25-123222.md) | [707](/filings/0001104659-26-032757.md) | [866](/filings/0001104659-26-073525.md) | [784](/filings/0001104659-25-123222.md) | [698](/filings/0001104659-26-032757.md) | [924](/filings/0001104659-26-073525.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [126](/filings/0001558370-23-019871.md) | [128](/filings/0001558370-24-003413.md) | [136](/filings/0001558370-24-009005.md) | [164](/filings/0001558370-24-016435.md) | [126](/filings/0001558370-25-003476.md) | [144](/filings/0001558370-25-008618.md) | [169](/filings/0001104659-25-123222.md) | [110](/filings/0001104659-26-032757.md) | [146](/filings/0001104659-26-073525.md) | [147](/filings/0001104659-25-123222.md) | [122](/filings/0001104659-26-032757.md) | [172](/filings/0001104659-26-073525.md) |
| Net income | $m | [539](/filings/0001558370-23-019871.md) | [477](/filings/0001558370-24-003413.md) | [648](/filings/0001558370-24-009005.md) | [593](/filings/0001558370-24-016435.md) | [515](/filings/0001558370-25-003476.md) | [652](/filings/0001558370-25-008618.md) | [565](/filings/0001104659-25-123222.md) | [488](/filings/0001104659-26-032757.md) | [608](/filings/0001104659-26-073525.md) | [531](/filings/0001104659-25-123222.md) | [469](/filings/0001104659-26-032757.md) | [641](/filings/0001104659-26-073525.md) |
| Diluted EPS | $ per share | [27.45](/filings/0001558370-23-019871.md) | [24.64](/filings/0001558370-24-003413.md) | [34.12](/filings/0001558370-24-009005.md) | [32.55](/filings/0001558370-24-016435.md) | [28.89](/filings/0001558370-25-003476.md) | [36.69](/filings/0001558370-25-008618.md) | [32.52](/filings/0001104659-25-123222.md) | [28.29](/filings/0001104659-26-032757.md) | [35.36](/filings/0001104659-26-073525.md) | [31.04](/filings/0001104659-25-123222.md) | [27.63](/filings/0001104659-26-032757.md) | [38.07](/filings/0001104659-26-073525.md) |
| Basic EPS | $ per share | [28.37](/filings/0001558370-23-019871.md) | [25.48](/filings/0001558370-24-003413.md) | [35.22](/filings/0001558370-24-009005.md) | [33.51](/filings/0001558370-24-016435.md) | [29.74](/filings/0001558370-25-003476.md) | [37.73](/filings/0001558370-25-008618.md) | [33.40](/filings/0001104659-25-123222.md) | [29.06](/filings/0001104659-26-032757.md) | [36.33](/filings/0001104659-26-073525.md) | [31.88](/filings/0001104659-25-123222.md) | [28.29](/filings/0001104659-26-032757.md) | [38.95](/filings/0001104659-26-073525.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-11-18) | Q2 FY2024 (2024-02-10) | Q3 FY2024 (2024-05-04) | FY2024 (2024-08-31) | Q1 FY2025 (2024-11-23) | Q2 FY2025 (2025-02-15) | Q3 FY2025 (2025-05-10) | FY2025 (2025-08-30) | Q1 FY2026 (2025-11-22) | Q2 FY2026 (2026-02-14) | Q3 FY2026 (2026-05-09) | FY2026 (2026-08-29) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.3](/filings/0001558370-23-019871.md) | [0.3](/filings/0001558370-24-003413.md) | [0.3](/filings/0001558370-24-009005.md) | [0.3](/filings/0001104659-25-102611.md) | [0.3](/filings/0001558370-24-016435.md) | [0.3](/filings/0001558370-25-003476.md) | [0.3](/filings/0001558370-25-008618.md) | [0.3](/filings/0001104659-26-118791.md) | [0.3](/filings/0001104659-25-123222.md) | [0.3](/filings/0001104659-26-032757.md) | [0.3](/filings/0001104659-26-073525.md) | [0.3](/filings/0001104659-26-118791.md) |
| Current assets | $bn | [7.0](/filings/0001558370-23-019871.md) | [7.2](/filings/0001558370-24-003413.md) | [7.3](/filings/0001558370-24-009005.md) | [7.3](/filings/0001104659-25-102611.md) | [7.4](/filings/0001558370-24-016435.md) | [7.8](/filings/0001558370-25-003476.md) | [8.0](/filings/0001558370-25-008618.md) | [8.3](/filings/0001104659-26-118791.md) | [8.4](/filings/0001104659-25-123222.md) | [8.8](/filings/0001104659-26-032757.md) | [8.9](/filings/0001104659-26-073525.md) | [9.1](/filings/0001104659-26-118791.md) |
| Total assets | $bn | [16.3](/filings/0001558370-23-019871.md) | [16.7](/filings/0001558370-24-003413.md) | [17.1](/filings/0001558370-24-009005.md) | [17.2](/filings/0001104659-25-102611.md) | [17.5](/filings/0001558370-24-016435.md) | [18.1](/filings/0001558370-25-003476.md) | [18.6](/filings/0001558370-25-008618.md) | [19.4](/filings/0001104659-26-118791.md) | [19.7](/filings/0001104659-25-123222.md) | [20.4](/filings/0001104659-26-032757.md) | [20.9](/filings/0001104659-26-073525.md) | [21.6](/filings/0001104659-26-118791.md) |
| Current liabilities | $bn | [8.8](/filings/0001558370-23-019871.md) | [8.8](/filings/0001558370-24-003413.md) | [9.2](/filings/0001558370-24-009005.md) | [8.7](/filings/0001104659-25-102611.md) | [8.9](/filings/0001558370-24-016435.md) | [9.3](/filings/0001558370-25-003476.md) | [9.5](/filings/0001558370-25-008618.md) | [9.5](/filings/0001104659-26-118791.md) | [9.8](/filings/0001104659-25-123222.md) | [9.9](/filings/0001104659-26-032757.md) | [10.0](/filings/0001104659-26-073525.md) | [10.1](/filings/0001104659-26-118791.md) |
| Long-term debt | $bn | [8.6](/filings/0001558370-23-019871.md) | [8.6](/filings/0001558370-24-003413.md) | [8.5](/filings/0001558370-24-009005.md) | [9.0](/filings/0001104659-25-102611.md) | [9.0](/filings/0001558370-24-016435.md) | [9.1](/filings/0001558370-25-003476.md) | [8.9](/filings/0001558370-25-008618.md) | [8.8](/filings/0001104659-26-118791.md) | [8.6](/filings/0001104659-25-123222.md) | [8.9](/filings/0001104659-26-032757.md) | [9.0](/filings/0001104659-26-073525.md) | [9.1](/filings/0001104659-26-118791.md) |
| Current portion of debt | $bn | not reported | not reported | [0.5](/filings/0001558370-24-009005.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [(5.2)](/filings/0001558370-25-003476.md) | [(4.8)](/filings/0001558370-25-008618.md) | [(4.8)](/filings/0001558370-25-008618.md) | [(4.7)](/filings/0001104659-26-118791.md) | [(4.7)](/filings/0001104659-26-032757.md) | [(4.5)](/filings/0001104659-26-073525.md) | [(4.0)](/filings/0001104659-26-073525.md) | [(3.4)](/filings/0001104659-26-118791.md) | [(3.2)](/filings/0001104659-26-032757.md) | [(2.9)](/filings/0001104659-26-073525.md) | [(2.8)](/filings/0001104659-26-073525.md) | [(2.5)](/filings/0001104659-26-118791.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2015 (2014-11-22) | Q1 FY2016 (2015-11-21) | Q1 FY2017 (2016-11-19) | Q1 FY2018 (2017-11-18) | Q1 FY2019 (2018-11-17) | Q1 FY2020 (2019-11-23) | Q1 FY2021 (2020-11-21) | Q1 FY2022 (2021-11-20) | Q1 FY2023 (2022-11-19) | Q1 FY2024 (2023-11-18) | Q1 FY2025 (2024-11-23) | Q1 FY2026 (2025-11-22) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [375](/filings/0001193125-15-404907.md) | [347](/filings/0001193125-16-793056.md) | [407](/filings/0001193125-17-373692.md) | [565](/filings/0001193125-18-351223.md) | [449](/filings/0001193125-19-320984.md) | [447](/filings/0001558370-20-014469.md) | [683](/filings/0001558370-21-016915.md) | [778](/filings/0001558370-22-018835.md) | [794](/filings/0001558370-23-019871.md) | [830](/filings/0001558370-24-016435.md) | [812](/filings/0001104659-25-123222.md) | [944](/filings/0001104659-25-123222.md) |
| Capital expenditure | $m | [92.4](/filings/0001193125-15-404907.md) | [86.7](/filings/0001193125-16-793056.md) | [97.9](/filings/0001193125-17-373692.md) | [110](/filings/0001193125-18-351223.md) | [98.2](/filings/0001193125-19-320984.md) | [101](/filings/0001558370-20-014469.md) | [113](/filings/0001558370-21-016915.md) | [102](/filings/0001558370-22-018835.md) | [114](/filings/0001558370-23-019871.md) | [235](/filings/0001558370-24-016435.md) | [247](/filings/0001104659-25-123222.md) | [314](/filings/0001104659-25-123222.md) |
| Share repurchases | $m | [300](/filings/0001193125-15-404907.md) | [400](/filings/0001193125-16-793056.md) | [363](/filings/0001193125-17-373692.md) | [353](/filings/0001193125-18-351223.md) | [497](/filings/0001193125-19-320984.md) | [450](/filings/0001558370-20-014469.md) | [678](/filings/0001558370-21-016915.md) | [900](/filings/0001558370-22-018835.md) | [900](/filings/0001558370-23-019871.md) | [1,487](/filings/0001558370-24-016435.md) | [540](/filings/0001104659-25-123222.md) | [427](/filings/0001104659-25-123222.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations, us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-11-19) | Q2 FY2023 (2023-02-11) | Q3 FY2023 (2023-05-06) | Q1 FY2024 (2023-11-18) | Q2 FY2024 (2024-02-10) | Q3 FY2024 (2024-05-04) | Q1 FY2025 (2024-11-23) | Q2 FY2025 (2025-02-15) | Q3 FY2025 (2025-05-10) | Q1 FY2026 (2025-11-22) | Q2 FY2026 (2026-02-14) | Q3 FY2026 (2026-05-09) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [19.6](/filings/0001558370-23-019871.md) | [19.3](/filings/0001558370-24-003413.md) | [19.0](/filings/0001558370-24-009005.md) | [18.2](/filings/0001558370-24-016435.md) | [17.8](/filings/0001558370-25-003476.md) | [17.8](/filings/0001558370-25-008618.md) | [17.4](/filings/0001104659-25-123222.md) | [17.2](/filings/0001104659-26-032757.md) | [17.2](/filings/0001104659-26-073525.md) | [17.1](/filings/0001104659-25-123222.md) | [17.0](/filings/0001104659-26-032757.md) | [16.9](/filings/0001104659-26-073525.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 16,094,341 at 2026-10-19, from the cover of the [10-K filed 2026-10-26](/filings/0001104659-26-118791.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 26, 2026, 16:44 ET. No prices; not investment advice.